These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15013946)

  • 1. Can food intake be reduced with peptide YY3-36?
    Doggrell SA
    Expert Opin Investig Drugs; 2004 Mar; 13(3):285-7. PubMed ID: 15013946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of food intake in obese subjects by peptide YY3-36.
    Batterham RL; Cohen MA; Ellis SM; Le Roux CW; Withers DJ; Frost GS; Ghatei MA; Bloom SR
    N Engl J Med; 2003 Sep; 349(10):941-8. PubMed ID: 12954742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin.
    Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR
    Int J Obes Relat Metab Disord; 2004 Jul; 28(7):886-93. PubMed ID: 15148507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of PYY3-36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men.
    Schmidt JB; Gregersen NT; Pedersen SD; Arentoft JL; Ritz C; Schwartz TW; Holst JJ; Astrup A; Sjödin A
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1248-56. PubMed ID: 24735885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass.
    Fenske WK; Bueter M; Miras AD; Ghatei MA; Bloom SR; le Roux CW
    Int J Obes (Lond); 2012 Mar; 36(3):379-84. PubMed ID: 21694700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin increases food intake in obese as well as lean subjects.
    Druce MR; Wren AM; Park AJ; Milton JE; Patterson M; Frost G; Ghatei MA; Small C; Bloom SR
    Int J Obes (Lond); 2005 Sep; 29(9):1130-6. PubMed ID: 15917842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome.
    Tan TM; Vanderpump M; Khoo B; Patterson M; Ghatei MA; Goldstone AP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4162-5. PubMed ID: 15292365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects.
    Steinert RE; Poller B; Castelli MC; Drewe J; Beglinger C
    Am J Clin Nutr; 2010 Oct; 92(4):810-7. PubMed ID: 20720259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide YY3-36 and pancreatic polypeptide suppress food intake.
    Asakawa A; Uemoto M; Ueno N; Katagi M; Fujimiya M; Fujino K; Kodama N; Nanba H; Sakamaki R; Shinfuku N; Meguid MM; Inui A
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1501-2. PubMed ID: 16911705
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of peptide YY3-36 on food intake in humans.
    Degen L; Oesch S; Casanova M; Graf S; Ketterer S; Drewe J; Beglinger C
    Gastroenterology; 2005 Nov; 129(5):1430-6. PubMed ID: 16285944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of peptide YY[3-36] on short-term food intake in mice are not affected by prevailing plasma ghrelin levels.
    Adams SH; Won WB; Schonhoff SE; Leiter AB; Paterniti JR
    Endocrinology; 2004 Nov; 145(11):4967-75. PubMed ID: 15284202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships Between Fasting Serum Amylase and Ghrelin or Peptide YY3-36 Levels in Healthy Men.
    Tak YJ; Yi YH; Lee SY; Kim YJ; Lee JG; Cho YH
    Pancreas; 2016 Mar; 45(3):376-80. PubMed ID: 26495778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of peripheral administration of PYY3-36 on feed intake and plasma acyl-ghrelin levels in pigs.
    Ito T; Thidarmyint H; Murata T; Inoue H; Neyra RM; Kuwayama H
    J Endocrinol; 2006 Oct; 191(1):113-9. PubMed ID: 17065394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity.
    Small CJ; Bloom SR
    Expert Opin Investig Drugs; 2005 May; 14(5):647-53. PubMed ID: 15926870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxyntomodulin suppresses appetite and reduces food intake in humans.
    Cohen MA; Ellis SM; Le Roux CW; Batterham RL; Park A; Patterson M; Frost GS; Ghatei MA; Bloom SR
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4696-701. PubMed ID: 14557443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The homeostatic dynamics of feeding behaviour identify novel mechanisms of anorectic agents.
    McGrath TM; Spreckley E; Rodriguez AF; Viscomi C; Alamshah A; Akalestou E; Murphy KG; Jones NS
    PLoS Biol; 2019 Dec; 17(12):e3000482. PubMed ID: 31805040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central responsiveness to a ghrelin mimetic (GHRP-6) is rapidly altered by acute changes in nutritional status in rats.
    Tung YC; Hewson AK; Carter RN; Dickson SL
    J Neuroendocrinol; 2005 Jun; 17(6):387-93. PubMed ID: 15929744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents.
    Ortiz AA; Milardo LF; DeCarr LB; Buckholz TM; Mays MR; Claus TH; Livingston JN; Mahle CD; Lumb KJ
    J Pharmacol Exp Ther; 2007 Nov; 323(2):692-700. PubMed ID: 17671099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
    Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
    Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial peptide YY is lower in young college-aged women with high dietary cognitive restraint.
    Scheid JL; Birch LL; Williams NI; Rolls BJ; De Souza MJ
    Physiol Behav; 2013 Aug; 120():26-33. PubMed ID: 23831742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.